Citizen reporter Curing malaria means also having to stop the transmission cycle, which the new potent chemical compounds will be able to do. Residents in Burkina Faso have struggled to contain malaria. Picture for illustration: iStock
The groundbreaking discovery was published in the
Nature Communications journal on Monday.
It involved identifying compounds able to kill several stages of the deadly human malaria parasite,
Plasmodium falciparum, which does occur in South Africa, explained UP’s Institute for Sustainable Malaria Control research chair, Professor Lyn-Marie Birkholtz.
The malaria-causing parasite is able to take on multiple forms. Some cause disease, and others allow the parasite to be transmitted back into mosquitos, to continue the deadly life cycle.
GSK and Medicines for Malaria Venture (MMV) announced today that the Australian Therapeutic Goods Administration (TGA) accepted the submission of a Category 1 application to extend the indication of single-dose Kozenis (tafenoquine) to paediatric populations for the radical cure (prevention of relapse) of Plasmodium vivax (P. vivax) malaria.The application includes data for a
A New Strain of Drug-Resistant Malaria Has Sprung Up in Africa
Here’s how we fight back
Advertisement
Ever since the deadly parasite responsible for malaria was discovered in the late 19th century, science and global health experts have been waging a vigorous Sisyphean battle against the disease it causes. Humans have brought an arsenal of tools nets, rapid tests, medication to bear against the mosquito-borne parasite, which cannily mutates to become resistant to drug treatments. We’re holding our own: Global malaria deaths declined to 409,000 in 2019, compared to 585,000 in 2010, and a number of countries have eliminated it altogether or are on the verge of doing so.
Malaria Prevention Pushes Forward in Africa Despite Pandemic medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Last modified on Wed 23 Dec 2020 14.02 EST
Experts fear a push to cut the UK’s aid budget will slash spending on global health research, handicapping international public-private programmes that have helped combat the world’s deadliest diseases over the last decade.
In a letter addressed to the foreign secretary, Dominic Raab, last week, prominent parliamentarians sought reassurance that the planned cuts would not lead to “dramatic reductions” in investment for devastating diseases such as tuberculosis, malaria, Aids and a clutch of neglected tropical diseases.
The letter’s signatories include the former health secretary Jeremy Hunt, the chair of the science and technology select committee, Greg Clark, the chair of the international development committee, Sarah Champion, and the Tory peer Nick Herbert, the letter’s lead signatory.